A breast cancer diagnostic startup that uses fingertip sensors to detect tumors has received a research grant of more than $878,000 to advance its handheld diagnostic device.
UE Lifesciences’ “Intelligent Breast Exam” can distinguish between normal breast tissue and a tumor. Breast cancers are stiffer and less mobile than the surrounding tissue, according to a paper documenting the device. Dr. Ari Brooks, chief of surgical oncology at the Drexel College of Medicine, said it has been particularly effective at detecting tumors in women under 40, based on the clinical trials the college of medicine has conducted.
The handheld device offers a non-invasive, radiation-free alternative to mammograms.
The Commonwealth Universal Research Enhancement grant will be used to advance the screening test to the final stages of development, according to a statement from Drexel.